Lupin intros generic Namenda XR
Lupin has launched its generic of Namenda XR (memantine hydrochloride extended release) capsules. The drug is indicated to treat moderate-to-severe dementia of the Alzheimer’s type.
Lupin’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $936 million for the 12 months ended December 2017, according to IQVIA data.
Lupin’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $936 million for the 12 months ended December 2017, according to IQVIA data.